Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26.8Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-1.4
Enterprise Value $M12.8EPS (TTM) $-2.0Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.7Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.010-y EBITDA Growth Rate %--Quick Ratio14.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio14.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-65.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-70.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M6.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PTIE

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PTIE is held by these investors:



PTIE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROBERTSON SANFORDDirector 2013-11-06Buy7,143$26.11-84.41view
FRIEDMANN NADAVCOO 2011-10-18Sell3,571$31.08-86.9view
FRIEDMANN NADAVCOO 2011-10-04Sell3,571$33.67-87.91view
Sabretooth Master Fund, L.P.10% Owner 2011-10-04Sell54,571$32.13-87.33view
FRIEDMANN NADAVCOO 2011-09-15Sell3,571$34.23-88.11view
Sabretooth Master Fund, L.P.10% Owner 2011-08-08Sell6,345$29.4-86.16view
BARBIER REMICEO, Chairman of the Board, 10% Owner 2011-08-08Buy714$29.54-86.22view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-10-04Sell7,143$43.4-90.62view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-07Sell4,085$39.83-89.78view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-02Sell3,058$40.67-89.99view

Press Releases about PTIE :

Quarterly/Annual Reports about PTIE:

News about PTIE:

Articles On GuruFocus.com
National Institute on Drug Abuse Awards Pain Therapeutics $2.2 Million Grant Sep 18 2017 
NIH Awards $1.8 Million Research Grant to Pain Therapeutics in Support of a Blood-based Diagnosti Sep 18 2017 
Pain Therapeutics Reports Q2 2017 Financial Results And Mid-year Corporate Update Aug 09 2017 
Pain Therapeutics Announces FDA Has Cleared an Investigational New Drug (IND) Application for PTI-12 Jul 31 2017 
NIH Awards $1.7 Million Research Grant to Pain Therapeutics to Study Alzheimer’s Disease Jun 05 2017 
Pain Therapeutics Announces Research Publication on Alzheimer’s Disease Jun 01 2017 
Pain Therapeutics Announces Reverse Stock Split May 08 2017 
Pain Therapeutics Reports First Quarter 2017 Financial Results Apr 25 2017 
Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY™ ER Mar 20 2017 
Wednesday Pre-Market Insights: GEVO, WPZ, HDP, PTIE May 13 2015 

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}